Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.
NCT ID: NCT05464797
Last Updated: 2022-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2020-12-12
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy
NCT07261761
Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay
NCT07171229
Pulp Inflammatory Markers and Outcome of Pulpotomy
NCT06960603
Hemostasis Achievement Reflecting Inflammatory Status of the Pulp Based on Cytokine Levels: A Cohort Study.
NCT03737682
Evaluation Of Different Pulpotomy Agents Used For Treatment Of Immature Molars
NCT05347160
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pulp inflammation occurs in a low compliance environment of dentinal walls. So, During acute inflammatory reaction, Vasodilatation occurs along with increased capillary permeability, Which leads to increase in the pulp interstitial fluid pressure which creates more pressure on blood vessels and this prevents beneficial blood flow, which decreases the ability of the pulp to defend itself from bacterial attacks causing tissue necrosis. This necrotic tissue is colonized by bacterial tissues.
In the literature, one of the novel treatment modalities for irrevesible inflammation of the pulp is partial removal of the inflammed pulp tissue according to clinical sign (bleeding control), The pulp tissue is removed partially until reaching complete coronal pulp removal or complete pulpectomy until hemostasis is obtained after 10 minutes of moist cotton pellet application.So, The normal pulp is preserved.
In 2019, Ricucci et al conducted a systematic review for treatment of deep carious lesions with pulp exposure. With treatment modalities ranging from direct pulp capping, partial pulpotomy, complete pulpotomy and pulpectomy. Based only on clinical signs of normal appearance of the pulp tissue under magnification with dental operating microscope and bleeding control within 10 minutes with a moist cotton pellet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Direct Pulp Capping group
Pulp therapy
partial or complete removal of inflamed pulp tissue
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Partial Pulpotomy group
Pulp therapy
partial or complete removal of inflamed pulp tissue
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Complete Pulpotomy group
Pulp therapy
partial or complete removal of inflamed pulp tissue
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Root canal treatment group
Pulp therapy
partial or complete removal of inflamed pulp tissue
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulp therapy
partial or complete removal of inflamed pulp tissue
Cytokines level in pulpal blood.
Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The age range from 15-45 years.
* Patients of both sex.
* Has clinical symptoms of pulpitis with normal apical tissues and supported by radiographic evaluation with no periradicular changes.
Exclusion Criteria
* Patients with clinical symptoms of periradicular inflammation or periradicular radiographic changes.
* Negative response to cold testing.
15 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Al Mansurah, Dakahliya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M02031120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.